The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus
- 4 March 2008
- journal article
- Published by Springer Nature in Nature Clinical Practice Endocrinology & Metabolism
- Vol. 4 (5) , 240-241
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Cytokines and β-Cell Biology: from Concept to Clinical TranslationEndocrine Reviews, 2007
- Increased Number of Islet-Associated Macrophages in Type 2 DiabetesDiabetes, 2007
- Interleukin-1–Receptor Antagonist in Type 2 Diabetes MellitusNew England Journal of Medicine, 2007
- Blocking IL-1 in systemic inflammationJournal of Experimental Medicine, 2005
- An immune origin of type 2 diabetes?Diabetologia, 2005
- Inflammatory Cytokines and the Risk to Develop Type 2 DiabetesDiabetes, 2003
- β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 DiabetesDiabetes, 2003
- Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ, 2000
- A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic isletsJournal of Autoimmunity, 1989